Skip to main content

Detecting those at high fracture risk

Deakin researchers have shown a weak link in the fracture risk tool FRAX.

What's new in Bipolar Disorder research?

On World Bipolar Day, IMPACT hosted a public seminar to outline the latest research.

Fractured lives

Men express less satisfaction with their quality of life after suffering a fracture.

Heavy metal and the blues

IMPACT researchers find a connection between cadmium and depression.

Muscle or fat?

Young men are less healthy than we thought - research shows an alarming increase in obesity.

Contact us


+61 4215 3320


IMPACT Strategic Research Centre (Barwon Health)
Deakin University
School of Medicine
PO Box 281
Geelong Victoria 3220

Our Team

Photo of the IMPACT SRC team

Dr Olivia Dean

Position: Postdoctoral Research Fellow
Phone: +61 3 4215 3300
Campus: Geelong - Barwon Health


University recorded publications

Researcher output profile for Dr Olivia Dean

Brief Biography

Dr. Olivia Dean is currently a Research Fellow within the School of Medicine, Deakin University and holds honorary appointments with the Mental Health Research Institute, the Department of Psychiatry, University of Melbourne and Barwon Health.

During her research career, Dr. Dean has been responsible for the development and coordination of several multi-centre, international clinical trials. Dr. Dean's current research interests include both basic and clinical science and centre around developing treatments targeting oxidative biology and inflammation in several psychiatric disorders. She is currently running several clinical trials investigating new therapies, targeting new pathways in depression, bipolar disorder, schizophrenia and autism. This research may not only benefit individuals with these disorders, but will also provide important evidence to better understand the underlying biological factors involved in the development of these disorders.

Dr. Olivia Dean has assisted in establishing several clinical trials investigating novel therapies for psychiatric illness. Since completing her PhD in 2008, Dr Dean has initiated several new trials investigating completely new therapies for psychiatry, focusing on pathways that have yet to be targeted with conventional psychiatric medications.

Dr. Dean's research has been recongised by several awards and support from funding organisations. To date, she has received funding from the Brain and Behavior Research Foundation, NHRMC, Simons Foundation, Australasian Society for Bipolar and Depressive Disorders Servier Grant, Australian Rotary Health, Marian and E.H. Flack Trust, Deakin University and the Stanley Medical Research Institute totalling over AU$ 4 million.

Dr Dean is currently involved in several professional societies and has reviewed manuscripts for many journals. Dr. Dean is actively supervising four PhD students and is open to supervising both PhD and Honours students interested in novel therapies in psychiatry.

Dr. Dean has published over 40 articles and one book chapter to date. These manuscripts have been published in several high impact factor journals including Trends in Pharmacological Science, Biological Psychiatry, Current Medicinal Chemistry, Journal of Clinical Psychiatry and Neuroscience & Biobehavioral Reviews.

Select another contact

Deakin University acknowledges the traditional land owners of present campus sites.

27th February 2015